Intestinal permeability in the assessment of intestinal toxicity of cytotoxic agents

Chemotherapy

Volumn 51, Issue 6, 2005, Pages 336-338

  Melichar, Bohuslav ^a   Dvořák, Josef ^a   Hyšpler, Radomír ^a   Zadák, Zdeněk ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Cancer; Cytotoxic drugs; Intestinal permeability

Indexed keywords

ALKYLATING AGENT; ANTINEOPLASTIC AGENT; CYTOTOXIC AGENT; DISACCHARIDE; DOXORUBICIN; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; MONOSACCHARIDE; SUGAR; XYLOSE;

ANAMNESIS; ARTICLE; BREAST CARCINOMA; CANCER CHEMOTHERAPY; CELIAC DISEASE; CLINICAL FEATURE; CORRELATION ANALYSIS; DIAGNOSTIC PROCEDURE; DIARRHEA; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG EFFECT; ENTERITIS; ENTEROPATHY; EXPOSURE; GASTROINTESTINAL TOXICITY; HUMAN; INFECTION; INTESTINE ABSORPTION; INTESTINE CRYPT; INTESTINE INJURY; INTESTINE MUCOSA; INTESTINE MUCOSA PERMEABILITY; INTESTINE VILLUS; LEUKEMIA; MALABSORPTION; MALIGNANT NEOPLASTIC DISEASE; METABOLISM; MONITORING; MUCOSA INFLAMMATION; NEUTROPENIC ENTEROCOLITIS; PRIORITY JOURNAL; SARCOMA; SIDE EFFECT; SYSTEMIC DISEASE; TIGHT JUNCTION;

ANTINEOPLASTIC AGENTS; HUMANS; INTESTINAL DISEASES; INTESTINAL MUCOSA; MUCOSITIS; NEOPLASMS; PERMEABILITY;

EID: 27544463072     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000088957     Document Type: Article

References (7)

1. Tsavaris NB, Polyzos A, Gennatas K, Kosmas C, Vadiaka M, Dimitrakopoulos A, Macheras A, Papastratis G, Tsipras H, Margaris H, Papalambros E, Giannopoulos A, Koufos C: Irinotecan (CPT-11) in patients with advanced colon carcinoma relapsing after 5-fluorouracilleucovorin combination. Chemotherapy 2002;48:94-99.
2. Bijlsma PB, Fihn BM, Sjoqvist A, Groot JA, Taminiau JAJM, Jodal M: Water absorption enhances the uptake of mannitol and decreases Cr-EDTA/mannitol permeability ratios in cat small intestine in situ. Scand J Gastroenterol 2002;37:799-806.
3. Parrilli G, Iaffaioli RV, Martorano M, Cuomo R, Tafuto S, Zampino MG, Budillon G, Bianco AR: Effects of anthracycline therapy on intestinal absorption in patients with advanced breast cancer. Cancer Res 1989;49:3689-3691.
4. Fazeny-Dorner B, Veitl M, Wenzel C, Brodowicz T, Zielinski C, Muhm M, Vogelsang H, Marosi C: Alterations in intestinal permeability following the intensified polydrug-chemotherapy IFADIC (ifosfamide, Adriamycin, dacarbazine). Cancer Chemother Pharmacol 2002;49:294-298.
5. Daniele B, Secondulfo M, De Vivo R, Pignata S, De Magistris L, Delrio P, Palaia R, Barletta E, Tambaro R, Carratu R: Effect of chemotherapy with 5-fluorouracil on intestinal permeability and absorption in patients with advanced colorectal cancer. J Clin Gastroenterol 2001;32:228-230.
6. Bow EJ, Loewen R, Cheang MS, Shore TB, Rubinger M, Schacter B: Cytotoxic therapy-induced D-xylose malabsorption and invasive infection during remission-induction therapy for acute myeloid leukemia in adults. J Clin Oncol 1997;15:2254-2261.
7. Melichar B, Kohout P, Bratova M, Solichova D, Kralickova P, Zadak Z: Intestinal permeability in patients with chemotherapy-induced stomatitis. J Cancer Res Clin Oncol 2001;127:314-318.